Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Del-1, an Endogenous Inhibitor of TGF-β Activation, Attenuates Fibrosis

Front Immunol. 2020; 
Kim DY, Lee SH, Fu Y, Jing F, Kim WY, Hong SB, Song JA, Choe H, Ryu HJ, Kim M, Lim D, Kim MS, Yun CO, Lee T, Hyun H, Choi EY.
Products/Services Used Details Operation
Gene Synthesis … Additionally, mouse Itgav cDNA (OriGene, Rockville, MD, USA) was cloned into the AgeI- NheI sites of the pUltra lentiviral vector, and mouse Itgb6 cDNA (GenScript, Piscataway, NJ, USA) was cloned into the AgeI-XbaI sites … Get A Quote

摘要

Uncontrolled activation of transforming growth factor (TGF)-β results in a wide range of pathologic conditions. Therapeutic interventions to regulate TGF-β signaling during fibrosis have been developed but the effectiveness is still limited. Here, we show that developmental endothelial locus-1 (Del-1) ameliorates fibrosis in mice by inhibiting αv integrin-mediated activation of TGF-β. Del-1 bound to αvβ6 integrin, an important activator of TGF-β, and inhibited the binding of αvβ6 integrin to the latency-associated peptide (LAP), thereby suppressing αv integrin-mediated activation of TGF-β. Lack of Del-1 increased colocalization of αv integrin and LAP in the lungs, which was reversed by Del-1 supplem... More

关键词

XML 地图